Sage Therapeutics Ownership | Who Owns Sage Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sage Therapeutics Ownership Summary


Sage Therapeutics is owned by 19.27% institutional investors, 10.41% insiders, and 70.32% retail investors. Blackrock is the largest institutional shareholder, holding 8.67% of SAGE shares. BB Biotech AG Ord is the top mutual fund, with 7.29% of its assets in Sage Therapeutics shares.

SAGE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSage Therapeutics19.27%10.41%70.32%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.22M8.67%$56.64M
Blackrock funding, inc. /de4.85M7.94%$26.34M
Vanguard group4.84M7.92%$26.27M
Madison avenue partners, lp4.48M7.24%$35.60M
Fmr4.12M6.74%$22.36M
Caligan partners lp3.05M4.93%$24.27M
Deep track capital, lp2.04M3.30%$16.21M
Acadian asset management1.59M2.59%$8.60M
Jacobs levy equity management1.43M2.37%$15.48M
Morgan stanley1.39M2.31%$15.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caligan partners lp3.05M5.06%$24.27M
Madison avenue partners, lp4.48M3.02%$35.60M
Adar1 capital management742.50K1.10%$5.90M
Kite lake capital management (uk) llp105.00K1.09%$834.75K
Deep track capital, lp2.04M0.52%$16.21M
Dafna capital management108.20K0.24%$860.19K
683 capital management630.00K0.21%$3.42M
Clearalpha technologies lp40.00K0.20%$318.00K
Boothbay fund management1.39M0.19%$7.54M
Pdt partners235.10K0.11%$1.28M

Top Buyers

HolderShares% AssetsChange
Madison avenue partners, lp4.48M3.02%4.48M
Deep track capital, lp2.04M0.52%2.04M
Boothbay fund management1.39M0.19%1.39M
Jacobs levy equity management1.43M0.06%870.16K
Adar1 capital management742.50K1.10%723.29K

Top Sellers

HolderShares% AssetsChange
Wellington management group llp39.65K0.00%-4.71M
Bellevue group---4.46M
Rtw investments, lp---3.00M
State street1.27M0.00%-1.65M
Millennium management309.54K0.00%-1.31M

New Positions

HolderShares% AssetsChangeValue
Madison avenue partners, lp4.48M3.02%4.48M$35.60M
Deep track capital, lp2.04M0.52%2.04M$16.21M
Boothbay fund management1.39M0.19%1.39M$7.54M
Susquehanna fundamental investments215.87K0.02%215.87K$1.17M
Tudor investment corp et al142.91K0.00%142.91K$1.14M

Sold Out

HolderChange
Dinuzzo private wealth-5.00
Principal securities-6.00
Jfs wealth advisors-8.00
Sjs investment consulting-8.00
Nelson, van denburg & campbell wealth management group-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202516-91.26%11,920,805-76.73%190.27%11-85.71%3-94.83%
Dec 31, 2024180-2.70%51,167,968-0.51%831.18%75-6.25%5915.69%
Sep 30, 2024185-8.87%51,430,442-3.85%841.06%81-25.69%51-3.77%
Jun 30, 2024200-5.21%53,449,131-8.16%880.94%1069.28%53-8.62%
Mar 31, 2024211-1.40%58,196,5443.77%971.11%9710.23%58-23.68%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
BB Biotech AG Ord4.46M7.29%-
Fidelity Growth Compy Commingled Pl O2.39M3.91%-
Vanguard Total Stock Mkt Idx Inv1.82M2.91%109.30K
Vanguard US Total Market Shares ETF1.71M2.78%-
SPDR® S&P Biotech ETF1.63M2.66%23.14K
iShares Russell 2000 ETF1.40M2.24%687.00
Vanguard Strategic Equity Inv1.07M1.71%412.85K
Vanguard Institutional Extnd Mkt Idx Tr873.73K1.40%1.57K
Federated Hermes MDT Small Cap Core IS821.66K1.31%52.21K
Federated Hermes MDT SCC Institutional821.66K1.31%52.21K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 09, 2023Barrett Elizabeth-Buy$37.28K
May 09, 2023Barrett Elizabeth-Buy$50.50K
Feb 10, 2023JONAS JEFFREY M-Sell$347.08K
Feb 10, 2023JONAS JEFFREY M-Sell$172.33K
Nov 10, 2022Greene Barry E President and CEOBuy$500.02K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--

SAGE Ownership FAQ


Who Owns Sage Therapeutics?

Sage Therapeutics shareholders are primarily institutional investors at 19.27%, followed by 10.41% insiders and 70.32% retail investors. The average institutional ownership in Sage Therapeutics's industry, Biotech Stocks , is 63.96%, which Sage Therapeutics falls below.

Who owns the most shares of Sage Therapeutics?

Sage Therapeutics’s largest shareholders are Blackrock (5.22M shares, 8.67%), Blackrock funding, inc. /de (4.85M shares, 7.94%), and Vanguard group (4.84M shares, 7.92%). Together, they hold 24.53% of Sage Therapeutics’s total shares outstanding.

Does Blackrock own Sage Therapeutics?

Yes, BlackRock owns 8.67% of Sage Therapeutics, totaling 5.22M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 56.64M$. In the last quarter, BlackRock increased its holdings by 323.43K shares, a 6.61% change.

Who is Sage Therapeutics’s biggest shareholder by percentage of total assets invested?

Caligan partners lp is Sage Therapeutics’s biggest shareholder by percentage of total assets invested, with 5.06% of its assets in 3.05M Sage Therapeutics shares, valued at 24.27M$.

Who is the top mutual fund holder of Sage Therapeutics shares?

BB Biotech AG Ord is the top mutual fund holder of Sage Therapeutics shares, with 7.29% of its total shares outstanding invested in 4.46M Sage Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools